1. Home
  2. ENSC vs LIDR Comparison

ENSC vs LIDR Comparison

Compare ENSC & LIDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENSC
  • LIDR
  • Stock Information
  • Founded
  • ENSC 2003
  • LIDR 2013
  • Country
  • ENSC United States
  • LIDR United States
  • Employees
  • ENSC N/A
  • LIDR N/A
  • Industry
  • ENSC Biotechnology: Pharmaceutical Preparations
  • LIDR Auto Parts:O.E.M.
  • Sector
  • ENSC Health Care
  • LIDR Consumer Discretionary
  • Exchange
  • ENSC Nasdaq
  • LIDR Nasdaq
  • Market Cap
  • ENSC 9.0M
  • LIDR 9.8M
  • IPO Year
  • ENSC N/A
  • LIDR N/A
  • Fundamental
  • Price
  • ENSC $6.45
  • LIDR $0.90
  • Analyst Decision
  • ENSC
  • LIDR Hold
  • Analyst Count
  • ENSC 0
  • LIDR 1
  • Target Price
  • ENSC N/A
  • LIDR N/A
  • AVG Volume (30 Days)
  • ENSC 63.3K
  • LIDR 6.4M
  • Earning Date
  • ENSC 03-14-2025
  • LIDR 02-20-2025
  • Dividend Yield
  • ENSC N/A
  • LIDR N/A
  • EPS Growth
  • ENSC N/A
  • LIDR N/A
  • EPS
  • ENSC N/A
  • LIDR N/A
  • Revenue
  • ENSC $4,421,404.00
  • LIDR $225,000.00
  • Revenue This Year
  • ENSC $89.78
  • LIDR N/A
  • Revenue Next Year
  • ENSC N/A
  • LIDR $2,650.00
  • P/E Ratio
  • ENSC N/A
  • LIDR N/A
  • Revenue Growth
  • ENSC 40.41
  • LIDR N/A
  • 52 Week Low
  • ENSC $2.12
  • LIDR $0.78
  • 52 Week High
  • ENSC $22.47
  • LIDR $5.15
  • Technical
  • Relative Strength Index (RSI)
  • ENSC 39.92
  • LIDR 41.59
  • Support Level
  • ENSC $6.61
  • LIDR $0.86
  • Resistance Level
  • ENSC $7.36
  • LIDR $0.99
  • Average True Range (ATR)
  • ENSC 0.65
  • LIDR 0.17
  • MACD
  • ENSC -0.13
  • LIDR -0.06
  • Stochastic Oscillator
  • ENSC 6.32
  • LIDR 10.39

About ENSC Ensysce Biosciences Inc.

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, the Trypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

About LIDR AEye Inc.

AEye Inc is a provider of high-performance, active lidar systems for vehicle autonomy, driver-assistance systems (ADAS), and robotic vision applications. The company's software-definable 4Sight Intelligent Sensing Platform combines solid-state active lidar, an optionally fused low-light HD camera, and integrated deterministic artificial intelligence to capture more intelligent information with less data, enabling faster, more accurate, and more reliable perception of the surroundings. Majority of the Company's revenue is generated from customers located in the United States followed by Europe, and Asia-Pacific.

Share on Social Networks: